论著
ENGLISH ABSTRACT
模拟临床的中性粒细胞性激素抵抗型支气管哮喘小鼠模型的建立及意义
王楠
陈子
葛林阳
王曦
高蕾
李涛
胡蓉
张明顺
周林福
作者及单位信息
·
DOI: 10.3760/cma.j.issn.1001-0939.2020.01.010
Establishment of a mouse model mimicking neutrophilic steroid-refractory asthma
Wang Nan
Chen Zi
Ge Linyang
Wang Xi
Gao Lei
Li Tao
Hu Rong
Zhang Mingshun
Zhou Linfu
Authors Info & Affiliations
Wang Nan
Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
Chen Zi
Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
Ge Linyang
Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
Wang Xi
Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
Gao Lei
Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
Li Tao
Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
Hu Rong
Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
Zhang Mingshun
Department of Immunology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing 211166, China
Zhou Linfu
Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
·
DOI: 10.3760/cma.j.issn.1001-0939.2020.01.010
1239
290
0
0
5
0
PDF下载
APP内阅读
摘要

目的建立一种模拟临床的中性粒细胞性激素抵抗型支气管哮喘(哮喘)小鼠模型并探讨其意义。

方法采用屋尘螨(house dust mite,HDM)和脂多糖(lipopolysaccharide,LPS)混合液,气管内给药建立哮喘小鼠模型。将18只雌性C57BL/6小鼠按照数字表法随机分为对照组、哮喘组(HDM+LPS)和地塞米松(dexamethasone,Dex)组(HDM+LPS+Dex)。肺功能仪测定小鼠气道阻力,HE染色观察肺组织炎症细胞浸润,过碘酸-雪夫染色(PAS)观察杯状细胞增生,瑞氏染色检测BALF炎症细胞总数及分类计数,聚合酶链式反应(PCR)和酶联免疫吸附试验(ELISA)检测肺组织和BALF炎症因子。流式细胞术检测肺组织Th17细胞分化。

结果HE染色显示,哮喘组肺组织炎症较对照组显著增高( P<0.05),地塞米松组肺组织炎症较哮喘组稍减轻( P>0.05);BALF细胞分类计数显示,哮喘组炎症细胞(除外嗜酸粒细胞)浸润较对照组显著增加[炎症细胞总数分别为(2797±400)×10 6/L和(105±75)×10 6/L,中性粒细胞计数分别为(1151±395)×10 6/L和(12±6)×10 6/L,淋巴细胞计数分别为(897±135)×10 6/L和(11±5)×10 6/L,巨噬细胞计数分别为(215±51)×10 6/L和(34±16)×10 6/L,均 P<0.05],地塞米松组肺组织炎症细胞总数及巨噬细胞计数较哮喘组显著下降[炎症细胞总数(1140±418)×10 6/L vs(2797±400)×10 6/L,巨噬细胞计数(117±31)×10 6/L vs(215±51)×10 6/L,均 P<0.05],但淋巴细胞和中性粒细胞计数无统计学意义[淋巴细胞计数(587±208)×10 6/L vs(897±135)×10 6/L,中性粒细胞计数(294±134)×10 6/L vs(1151±395)×10 6/L,均 P>0.05];免疫组织化学检测结果同样证实,地塞米松组肺组织中性粒细胞浸润较哮喘组不能被有效抑制;哮喘组和地塞米松组气道阻力较对照组均显著增高( P<0.05),但两组间气道阻力差异无统计学意义( P>0.05);与哮喘组相比,地塞米松组肺组织Th2炎症指标显著降低(均 P<0.05),而Th17细胞炎症指标有升高趋势,Th1炎症指标无显著改善;流式细胞术显示,地塞米松组肺组织Th17细胞浸润较哮喘组显著增多[分别为(5.8±1.9)%和(2.3±0.8)%, P<0.01]。

结论成功建立了一种模拟临床的中性粒细胞性哮喘小鼠模型。地塞米松非但不能抑制小鼠中性粒细胞气道炎症和气道高反应性,而且促进Th17细胞分化,印证该哮喘模型存在激素抵抗。

哮喘;地塞米松;中性粒细胞;Th17细胞
ABSTRACT

ObjectiveTo establish a murine model of neutrophilic steroid-refractory asthma for a better exploration of its pathogenesis and treatment.

MethodsA mouse model of neutrophilic steroid-refractory asthma was established by intratracheal administration of a mixture of house dust mite (HDM) and lipopolysaccharide (LPS). Eighteen female C57BL/6 mice were randomly divided into a control group, an asthma group (HDM+LPS) and a dexamethasone (Dex) group (HDM+LPS+Dex). The airway resistance was measured by pulmonary function test. Airway inflammation, hypersecretion and inflammatory cell recruitment were observed by HE, PAS and Wright′s staining, respectively. Inflammatory mediators in lung and bronchoalveolar lavage fluid (BALF) were detected by PCR and ELISA. Th17 cell differentiation in the lung was analyzed by flow cytometry.

ResultsHE staining showed a significantly increased airway inflammation in the asthma group than that in the control group ( P<0.05), and a slightly decreased airway inflammation in the Dex group than that in the asthma group ( P>0.05). Cell counts in BALF showed a sharply elevated recruitment of inflammatory cells in the asthma group (except eosinophils) than that in the control group (total number of inflammatory cells (2797±400)×10 6/L vs (105±75)×10 6/L, neutrophils (1151±395)×10 6/L vs (12±6)×10 6/L, lymphocytes(897±135)×10 6/L vs (11±5)×10 6/L, macrophages (215±51)×10 6/L vs (34±16)×10 6/L, P<0.05). Compared with the asthma group, Dex group significantly reduced the recruitment of total number of inflammatory cells and macrophages [total number of inflammatory cells (1140±418)×10 6/L vs (2797±400)×10 6/L, macrophages (117±31)×10 6/L vs (215±51)×10 6/L, all P<0.05]albeit no significances in lymphocytes and neutrophils [lymphocytes (587±208)×10 6/L vs (897±135)×10 6/L, neutrophils (294±134)×10 6/L vs (1151±395)×10 6/L, all P>0.05]. Immunohistochemical staining confirmed that Dex could not effectively alleviate the neutrophilic inflammation in asthmatic mice. Although there was no significant difference in airway hyperreactivity between the asthma group and the Dex group ( P>0.05), both had a higher airway hyperreactivity than that of the control group ( P<0.05). The Dex group exhibited a significantly lower Th2-related inflammatory mediators in the lung than the asthma group (all P<0.05), together with an increased trend in Th17 cell-related inflammatory mediators and no improvement in Th1-related inflammatory mediators. Flow cytometry showed an obviously increased percentage of Th17 cells in the Dex group than that in the asthma group [(5.8±1.9)% vs (2.3±0.8)%, P<0.01].

ConclusionA novel murine model mimicking clinical neutrophilic asthma was elegantly established, in which Dex could not attenuate the neutrophilic airway inflammation and hyperreactivity, but rather augmented Th17 cell differentiation, demonstrating the presence of steroid-resistance.

Asthma;Dexamethasone;Neutrophils;Th17 cells
Zhou Linfu, Email: nc.defudabe.umjnuohzfl
引用本文

王楠,陈子,葛林阳,等. 模拟临床的中性粒细胞性激素抵抗型支气管哮喘小鼠模型的建立及意义[J]. 中华结核和呼吸杂志,2020,43(1):40-46.

DOI:10.3760/cma.j.issn.1001-0939.2020.01.010

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
支气管哮喘(哮喘)是一种常见的慢性气道炎症性疾病。全球哮喘患者逾3亿,预计到2020年哮喘患者将增至4亿 [ 1 ]。重症哮喘(难治性哮喘)是临床治疗的瓶颈问题。重症哮喘与中性粒细胞性炎症而非嗜酸粒细胞性炎症密切相关 [ 2 ]。重症哮喘患者气道嗜酸粒细胞减少,中性粒细胞增加 [ 3 ]。重症哮喘与外周血、BALF、痰液和支气管活检标本中性粒细胞数增加有关 [ 4 , 5 ]。本研究旨在建立一种模拟临床的中性粒细胞性哮喘模型,为中性粒细胞性哮喘的发病机制及其治疗提供一个较好的实验动物模型。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Boulet LP , Reddel HK , Bateman E ,et al. The Gl obal Initiative for Asthma (GINA): 25 years later [J]. Eur Respir J, 2019,54(2). DOI: 10.1183/13993003.00598-2019 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Wu W , Bang S , Bleecker ER ,et al. Multiview cluster analysis identifies variable corticosteroid response phenotypes in severe asthma[J]. Am J Respir Crit Care Med, 2019,199(11):1358-1367. DOI: 10.1164/rccm.201808-1543OC .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Kelly EA , Esnault S , Liu LY ,et al. Mepolizumab attenuates airway eosinophil numbers, but not their functional phenotype, in asthma[J]. Am J Respir Crit Care Med, 2017,196(11):1385-1395. DOI: 10.1164/rccm.201611-2234OC .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Allinne J , Scott G , Lim WK ,et al. IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation[J]. J Allergy Clin Immunol, 2019. DOI: 10.1016/j.jaci.2019.08.039 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Ray A , Kolls JK . Neutrophilic inflammation in asthma and association with disease severity[J]. Trends Immunol, 2017,38(12):942-954. DOI: 10.1016/j.it.2017.07.003 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Qian G , Jiang W , Zou B ,et al. LPS inactivation by a host lipase allows lung epithelial cell sensitization for allergic asthma[J]. J Exp Med, 2018,215(9):2397-2412. DOI: 10.1084/jem.20172225 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Yu Q , Yu X , Zhao W ,et al. Inhibition of H3K27me3 demethylases attenuates asthma by reversing the shift in airway smooth muscle phenotype[J]. Clin Exp Allergy, 2018,48(11):1439-1452. DOI: 10.1111/cea.13244 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Li RF , Wang GF . JAK/STAT5 signaling pathway inhibitor ruxolitinib reduces airway inflammation of neutrophilic asthma in mice model [J]. Eur Rev Med Pharmacol Sci, 2018,22(3):835-843. DOI: 10.26355/eurrev_201802_14320 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Bullone M , Carriero V , Bertolini F ,et al. Elevated serum IgE, oral corticosteroid dependence and IL-17/22 expression in highly neutrophilic asthma[J]. Eur Respir J, 2019,54(5). DOI: 10.1183/13993003.00068-2019 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
中华医学会呼吸病学分会哮喘学组. 难治性哮喘诊断与处理专家共识[J]. 中华结核和呼吸杂志, 2010,33(8):572-577. DOI: 10.3760/cma.j.issn.1001-0939.2010.08.008 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
2019 GINA report, global strategy for asthma management and prevention. [EB/OL]. https://ginasthma.org/gina-reports/.
[12]
Israel E , Reddel HK . Severe and difficult-to-treat asthma in adults[J]. N Engl J Med, 2017,377(10):965-976. DOI: 10.1056/NEJMra1608969 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
McGregor MC , Krings JG , Nair P ,et al. Role of Biologics in Asthma[J]. Am J Respir Crit Care Med, 2019,199(4):433-445. DOI: 10.1164/rccm.201810-1944CI .
返回引文位置Google Scholar
百度学术
万方数据
[14]
苗伟伟汪凤凤李红岩. 奥马珠单抗在难治性哮喘治疗中的价值[J]. 中华结核和呼吸杂志, 2012,35(3):198-200. DOI: 10.3760/cma.j.issn.1001-0939.2012.03.012 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Corren J , Weinstein S , Janka L ,et al. Phase 3 study of reslizumab in patients with poorly controlled asthma: effects across a broad range of eosinophil counts[J]. Chest, 2016,150(4):799-810. DOI: 10.1016/j.chest.2016.03.018 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Bleecker ER , FitzGerald JM , Chanez P ,et al. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre , placebo-controlled phase 3 trial [J]. Lancet, 2016,388(10056):2115-2127. DOI: 10.1016/S0140-6736(16)31324-1 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Chen Z , Bai FF , Han L ,et al. Targeting Neutrophils in Severe Asthma via Siglec-9[J]. Int Arch Allergy Immunol, 2018,175(1-2):5-15. DOI: 10.1159/000484873 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Gubernatorova EO , Namakanova OA , Tumanov AV ,et al. Mouse models of severe asthma for evaluation of therapeutic cytokine targeting[J]. Immunol Lett, 2019,207:73-83. DOI: 10.1016/j.imlet.2018.11.012 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
王曦王楠陈子. 过敏进程是治疗过敏性哮喘的新途径[J]. 中华结核和呼吸杂志, 2019,42(6):454-458. DOI: 10.3760/cma.j.issn.1001-0939.2019.06.010 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Stevenson CS , Birrell MA . Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance[J]. Pharmacol Ther, 2011,130(2):93-105. DOI: 10.1016/j.pharmthera.2010.10.008 .
返回引文位置Google Scholar
百度学术
万方数据
[21]
Ravanetti L , Dijkhuis A , Sabogal Pineros YS ,et al. An early innate response underlies severe influenza-induced exacerbations of asthma in a novel steroid-insensitive and anti-IL-5-responsive mouse model[J]. Allergy, 2017,72(5):737-753. DOI: 10.1111/all.13057 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
Matsuse H , Fukushima C , Fukahori S ,et al. Differential effects of dexamethasone and itraconazole on Aspergillus fumigatus-exacerbated allergic airway inflammation in a murine model of mite-sensitized asthma[J]. Respiration, 2013,85(5):429-435. DOI: 10.1159/000345861 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Zhang Z , Biagini Myers JM , Brandt EB ,et al. β-Glucan exacerbates allergic asthma i ndependent of fungal sensitization and promotes steroid-resistant TH2/TH17 responses [J]. J Allergy Clin Immunol, 2017,139(1):54-65.e8. DOI: 10.1016/j.jaci.2016.02.031 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
Maurer M , Giménez-Arnau AM , Sussman G ,et al. Ligelizumab for chronic spontaneous urticaria[J]. N Engl J Med, 2019,381(14):1321-1332. DOI: 10.1056/NEJMoa1900408 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
周林福,Email: nc.defudabe.umjnuohzfl
B
所有作者均声明不存在利益冲突
C
国家重点研发计划 (2018YFC1313600)
国家自然科学基金重点国际(地区)合作研究项目 (81820108001)
国家自然科学基金项目 (81670029,81370133,81170018)
江苏省医学重点人才项目 (ZDRCA2016018)
江苏省333高层次人才工程第二层次培养对象 (BRA2019078)
江苏省社会发展重点研发专项 (BE2015651)
江苏省研究生科研创新计划 (KYCX171285)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号